Online pretreatment verification of high-dose rate brachytherapy using an imaging panel

Brachytherapy is employed to treat a wide variety of cancers. However, an accurate treatment verification method is currently not available. This study describes a pre-treatment verification system that uses an imaging panel (IP) to verify important aspects of the treatment plan. A detailed modelling of the IP was only possible with an extensive calibration performed using a robotic arm. Irradiations were performed with a high dose rate (HDR) 192Ir source within a water phantom. An empirical fit was applied to measure the distance between the source and the detector so 3D Cartesian coordinates of the dwell positions can be obtained using a single panel. The IP acquires 7.14 fps to verify the dwell times, dwell positions and air kerma strength (Sk). A gynecological applicator was used to create a treatment plan that was registered with a CT image of the water phantom used during the experiments for verification purposes. Errors (shifts, exchanged connections and wrong dwell times) were simulated to verify the proposed verification system. Cartesian source positions (panel measurement plane) have a standard deviation of about 0.02 cm. The measured distance between the source and the panel (z-coordinate) have a standard deviation up to 0.16 cm and maximum absolute error of  ≈0.6 cm if the signal is close to sensitive limit of the panel. The average response of the panel is very linear with Sk. Therefore, Sk measurements can be performed with relatively small errors. The measured dwell times show a maximum error of 0.2 s which is consistent with the acquisition rate of the panel. All simulated errors were clearly identified by the proposed system. The use of IPs is not common in brachytherapy, however, it provides considerable advantages. It was demonstrated that the IP can accurately measure Sk, dwell times and dwell positions.

[1]  F. Verhaegen,et al.  In vivo dosimetry for gynaecological brachytherapy using a novel position sensitive radiation detector: feasibility study. , 2012, Medical physics.

[2]  J F Williamson,et al.  Code of practice for brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group No. 56. American Association of Physicists in Medicine. , 1997, Medical physics.

[3]  Clive Baldock,et al.  Experimental investigation of the response of an amorphous silicon EPID to intensity modulated radiotherapy beams. , 2007, Medical physics.

[4]  A. Rosenfeld,et al.  In vivo dosimetry: trends and prospects for brachytherapy. , 2014, The British journal of radiology.

[5]  J. Valentin Prevention of high-dose-rate brachytherapy accidents , 2005 .

[6]  E. Poon,et al.  Imaging with Iridium photons: an application in brachytherapy , 2007, SPIE Medical Imaging.

[7]  Frank Verhaegen,et al.  Time dependent pre-treatment EPID dosimetry for standard and FFF VMAT , 2014, Physics in medicine and biology.

[8]  F. Verhaegen,et al.  HDR 192Ir source speed measurements using a high speed video camera. , 2014, Medical physics.

[9]  Jeffrey F Williamson,et al.  Brachytherapy technology and physics practice since 1950: a half-century of progress , 2006, Physics in medicine and biology.

[10]  Kari Tanderup,et al.  Time-resolved in vivo luminescence dosimetry for online error detection in pulsed dose-rate brachytherapy. , 2009, Medical physics.

[11]  A Haworth,et al.  Source position verification and dosimetry in HDR brachytherapy using an EPID. , 2013, Medical physics.

[12]  Frank Verhaegen,et al.  Measured vs simulated portal images for low MU fields on three accelerator types: possible consequences for 2D portal dosimetry. , 2012, Medical physics.

[13]  M van Herk,et al.  Comparison of ghosting effects for three commercial a-Si EPIDs. , 2006, Medical physics.

[14]  B. McCurdy,et al.  Dosimetric investigation and portal dose image prediction using an amorphous silicon electronic portal imaging device. , 2001, Medical physics.

[15]  Patrick McCavana,et al.  Experimental investigation of the response of an a-Si EPID to an unflattened photon beam from an Elekta Precise linear accelerator. , 2009, Medical physics.

[16]  Kari Tanderup,et al.  In vivo dosimetry in brachytherapy. , 2013, Medical physics.

[17]  J. Valentin Preface, Main Points, Introduction, Chapters 2 and 3 , 2005 .

[18]  J. Williamson,et al.  Report of the Task Group 186 on model-based dose calculation methods in brachytherapy beyond the TG-43 formalism: current status and recommendations for clinical implementation. , 2012, Medical physics.

[19]  J J Sonke,et al.  Dose-response and ghosting effects of an amorphous silicon electronic portal imaging device. , 2003, Medical physics.

[20]  B Reniers,et al.  The contribution from transit dose for 192Ir HDR brachytherapy treatments , 2014, Physics in medicine and biology.

[21]  R. Taylor,et al.  EGSnrc Monte Carlo calculated dosimetry parameters for Ir192 and Yb169 brachytherapy sources. , 2008, Medical physics.

[22]  J. Lambert,et al.  In vivo dosimeters for HDR brachytherapy: a comparison of a diamond detector, MOSFET, TLD, and scintillation detector. , 2007, Medical physics.

[23]  E Pantelis,et al.  Current state of the art brachytherapy treatment planning dosimetry algorithms. , 2014, The British journal of radiology.

[24]  Joao Seco,et al.  Monte Carlo modelling of a-Si EPID response: the effect of spectral variations with field size and position. , 2006, Medical physics.